Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Patients of African-American descent or patient with a history of multiple transplants and/or patients with a high panel reactive antibody lab test with a renal transplant from a cadaveric donor, a living unrelated donor or a living-related mismatched donor.~* Age \>= 13 years, weight \>= 40 kg~* Women must have a negative pregnancy test at study entry~Exclusion criteria~* Multiple organ transplants or double kidney transplants (pediatric en-bloc or double adult)~* Active systemic infection, or localized major infection or known HIV~* Patients with residual kidney function \>20 mL/min

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).